IMMP
Immutep Limited American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Immutep (IMMP) Stock: Buy, Sell, or Hold?
$3.56
+0.10 (+2.89%)
â˛
5d:
+20.68%
30d:
-0.28%
90d:
+782.28%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
39/100
Position
FAIR
30-Day Fair Range
$3.01 â $3.78
Position: FAIR
Forward P/E & Valuation
-13.7x
Next 12M consensus est.
Wall Street Target
$30.00
+742.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.66 / $3.92
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IMMP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When IMMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMMP is currently trading at $3.56, which is considered fair relative to its 30-day fair value range of $3.01 to $3.78.
Technical Outlook: Technically, IMMP is in a strong uptrend. Immediate support is located at $2.66, while resistance sits at $3.92.
Market Sentiment: IMMP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+742.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMMP is in a strong uptrend. Immediate support is located at $2.66, while resistance sits at $3.92.
Market Sentiment: IMMP scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+742.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.01 -
$3.78
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$3.01 -
$3.78
Current vs Trading Range
FAIR
Support Level
$2.66
Resistance Level
$3.92
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 742.7% below Wall St target ($30.00)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-13.69
Wall Street Target
$30.00
(+742.7%)
Revenue Growth (YoY)
633.5%
Share IMMP Analysis
Share this live IMMP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 3:35 AM ET
Data refreshes hourly during market hours. Next update: 4:35 AM
Data refreshes hourly during market hours. Next update: 4:35 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma CompâĻ |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMMP Research Pages
